Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079476893> ?p ?o ?g. }
- W2079476893 endingPage "149" @default.
- W2079476893 startingPage "140" @default.
- W2079476893 abstract "Summary: It is estimated 20–25% of the epileptic patients fails to achieve good control with the different antiepileptic drugs (AEDs) treatments, developing refractory epilepsy (RE). Discovered first in cancer, the activity of P‐glycoprotein (P‐gp) and others ABC transporters as multidrug‐resistance‐associated proteins (MRPs) and breast cancer resistant protein (BCRP) are directly related with the refractoriness. We have observed the overexpression of these all transporters in the brain of patients with RE, and according with other authors, all these data suggests an active drug efflux from brain. Both constitutive and seizure induced brain P‐gp overexpression was also suggested. As confirmation of these clinical evidences, different models of experimental epilepsy have demonstrated P‐gp overexpression on blood brain barrier (BBB) and brain parenchyma cells, as astrocytes and neurons. In our model, early P‐pg detection in vessel‐related cells and later additional P‐gp detection in neurons, correlated with the gradual loss of protective effect of phenytoin. The progressive neuronal P‐gp expression, depending on intensity and time‐constancy of seizure‐injury, was in agreement with the development of “P‐gp‐positive seizure‐axis” proposed by Kwan & Brodie, who also showed that the development of RE directly correlated with the number and frequency of seizures before initiation of drug therapy. P‐gp expression in excretory organs suggests that P‐gp have a central role in drug elimination. Persistent low levels of AEDs in plasma and P‐gp brain overexpression in several RE pediatric patients were reported. We also observed in adult RE patients, an increased liver clearance of 99m Tc‐hexakis‐2‐methoxyisobutylisonitrile ( 99m Tc‐MIBI) (a P‐gp substrate), and the surgically treated cases showed P‐gp brain overexpression. These results suggest the systemic hyperactivity of P‐gp in RE patients, including brain P‐gp over‐expression should be suspected when persistent subtherapeutic levels of AEDs in plasma are detected. P‐gp neuronal expression described in both clinical and experimental reports indicates that additional mechanisms could be operative from seizure‐affected P‐gp‐positive neurons, due to AEDs targets are expressed at membrane level. An alternative mechanism was demonstrated in P‐gp‐expressed cells that exhibit lower membrane potential ( Δψ 0 =−10 to –20) compared to normal physiological Δψ 0 of –60 mV. Under this situation and irrespective to the P‐gp pharmacoresistant property or type of drug treatment selected, P‐gp‐expressed neurons could increase their sensitivity to new seizures perhaps as an epileptogenic mechanism. The understanding of properties of these ABC transporters can offer new tools for better selection of more effective preventive or therapeutic strategies and avoid the invasive surgical treatments for RE." @default.
- W2079476893 created "2016-06-24" @default.
- W2079476893 creator A5025268880 @default.
- W2079476893 creator A5026446372 @default.
- W2079476893 creator A5043993491 @default.
- W2079476893 creator A5052210949 @default.
- W2079476893 creator A5062950941 @default.
- W2079476893 creator A5071743499 @default.
- W2079476893 date "2007-09-01" @default.
- W2079476893 modified "2023-10-18" @default.
- W2079476893 title "ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy" @default.
- W2079476893 cites W1480812936 @default.
- W2079476893 cites W1499191315 @default.
- W2079476893 cites W1539389699 @default.
- W2079476893 cites W1598432003 @default.
- W2079476893 cites W1964150528 @default.
- W2079476893 cites W1966318231 @default.
- W2079476893 cites W1974809694 @default.
- W2079476893 cites W1979998728 @default.
- W2079476893 cites W1980319850 @default.
- W2079476893 cites W1991562104 @default.
- W2079476893 cites W1993155812 @default.
- W2079476893 cites W2020441233 @default.
- W2079476893 cites W2022589478 @default.
- W2079476893 cites W2023131642 @default.
- W2079476893 cites W2023701800 @default.
- W2079476893 cites W2024096384 @default.
- W2079476893 cites W2027150001 @default.
- W2079476893 cites W2027177883 @default.
- W2079476893 cites W2036004207 @default.
- W2079476893 cites W2038777102 @default.
- W2079476893 cites W2049520769 @default.
- W2079476893 cites W2053178768 @default.
- W2079476893 cites W2056207663 @default.
- W2079476893 cites W2057928306 @default.
- W2079476893 cites W2059141172 @default.
- W2079476893 cites W2061928059 @default.
- W2079476893 cites W2065075278 @default.
- W2079476893 cites W2067703397 @default.
- W2079476893 cites W2069118421 @default.
- W2079476893 cites W2077355747 @default.
- W2079476893 cites W2082440113 @default.
- W2079476893 cites W2083767702 @default.
- W2079476893 cites W2086215916 @default.
- W2079476893 cites W2090855710 @default.
- W2079476893 cites W2091406481 @default.
- W2079476893 cites W2103467580 @default.
- W2079476893 cites W2104290477 @default.
- W2079476893 cites W2107879632 @default.
- W2079476893 cites W2114714973 @default.
- W2079476893 cites W2114979307 @default.
- W2079476893 cites W2115626320 @default.
- W2079476893 cites W2118234018 @default.
- W2079476893 cites W2126487804 @default.
- W2079476893 cites W2131430137 @default.
- W2079476893 cites W2139154816 @default.
- W2079476893 cites W2147841481 @default.
- W2079476893 cites W2147926788 @default.
- W2079476893 cites W2148776940 @default.
- W2079476893 cites W2164604975 @default.
- W2079476893 cites W2333998271 @default.
- W2079476893 cites W2412945974 @default.
- W2079476893 cites W2605864756 @default.
- W2079476893 cites W4236676256 @default.
- W2079476893 cites W4312747745 @default.
- W2079476893 cites W4321429273 @default.
- W2079476893 doi "https://doi.org/10.1111/j.1528-1167.2007.01302.x" @default.
- W2079476893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17910594" @default.
- W2079476893 hasPublicationYear "2007" @default.
- W2079476893 type Work @default.
- W2079476893 sameAs 2079476893 @default.
- W2079476893 citedByCount "189" @default.
- W2079476893 countsByYear W20794768932012 @default.
- W2079476893 countsByYear W20794768932013 @default.
- W2079476893 countsByYear W20794768932014 @default.
- W2079476893 countsByYear W20794768932015 @default.
- W2079476893 countsByYear W20794768932016 @default.
- W2079476893 countsByYear W20794768932017 @default.
- W2079476893 countsByYear W20794768932018 @default.
- W2079476893 countsByYear W20794768932019 @default.
- W2079476893 countsByYear W20794768932020 @default.
- W2079476893 countsByYear W20794768932021 @default.
- W2079476893 countsByYear W20794768932022 @default.
- W2079476893 countsByYear W20794768932023 @default.
- W2079476893 crossrefType "journal-article" @default.
- W2079476893 hasAuthorship W2079476893A5025268880 @default.
- W2079476893 hasAuthorship W2079476893A5026446372 @default.
- W2079476893 hasAuthorship W2079476893A5043993491 @default.
- W2079476893 hasAuthorship W2079476893A5052210949 @default.
- W2079476893 hasAuthorship W2079476893A5062950941 @default.
- W2079476893 hasAuthorship W2079476893A5071743499 @default.
- W2079476893 hasBestOaLocation W20794768931 @default.
- W2079476893 hasConcept C104317684 @default.
- W2079476893 hasConcept C114851261 @default.
- W2079476893 hasConcept C118552586 @default.
- W2079476893 hasConcept C126322002 @default.
- W2079476893 hasConcept C133936738 @default.
- W2079476893 hasConcept C142424586 @default.